TherapeuticsMD (TXMD) Inventory Average (2012 - 2022)

TherapeuticsMD's Inventory Average history runs 10 years deep, the most recent figure standing at $6.4 million for Q3 2022.

• Quarterly Inventory Average fell 13.96% year-over-year to $6.4 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $6.4 million (down 13.96% YoY) and the FY2021 annual result came in at $7.8 million, down 21.35% from the prior year.
• Inventory Average was $6.4 million for Q3 2022 at TherapeuticsMD, down from $7.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $13.2 million in Q1 2020 and bottomed at $1.6 million in Q1 2018.
• A 5-year average of $7.1 million and a median of $7.5 million in 2021 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2019 — Inventory Average jumped 323.3% — and 2021, when it slumped 42.05%.
• TherapeuticsMD's Inventory Average stood at $2.8 million in 2018, then surged by 296.63% to $11.2 million in 2019, then declined by 19.95% to $9.0 million in 2020, then retreated by 16.41% to $7.5 million in 2021, then dropped by 14.24% to $6.4 million in 2022.
• Business Quant data shows TXMD's Inventory Average at $6.4 million in Q3 2022, $7.6 million in Q2 2022, and $8.3 million in Q1 2022.